康德莱：8月25日召开董事会会议

Group 1 - The core point of the article is that Kangdelai (SH 603987) announced a board meeting to discuss the replacement of the accounting firm and reported its revenue structure for 2024, with a significant focus on the medical device manufacturing sector [1][1][1] - Kangdelai's revenue composition for the year 2024 indicates that 99.6% of its revenue comes from the medical device manufacturing industry, while other businesses contribute only 0.4% [1][1][1] - As of the report, Kangdelai has a market capitalization of 3.8 billion yuan [1][1][1] Group 2 - The A-share market has seen trading volumes exceed 2 trillion yuan for eight consecutive days, indicating strong market activity [1][1][1] - Major brokerage firms are actively recruiting for autumn positions, highlighting a demand for talent in the industry [1][1][1]